Han Biomedical (ROCO:6999) NonCurrent Deferred Liabilities: NT$0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6999 Han Biomedical Inc ROCO:6999
32 GF Score
Price NT$28.45
! 2 Warning Signs
View Full Analysis

What is Han Biomedical NonCurrent Deferred Liabilities?

Han Biomedical ROCO:6999 32 NonCurrent Deferred Liabilities is NT$0.0 Mil as of Jun. 2026. GuruFocus rates ROCO:6999 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Han Biomedical's non-current deferred liabilities for the quarter that ended in Jun. 2026 was NT$0.0 Mil.

Han Biomedical NonCurrent Deferred Liabilities Related Terms

Han Biomedical NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Han Biomedical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical NonCurrent Deferred Liabilities Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
0.00 0.00 0.00 0.00 0.00

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6999
32GF Score
Han Biomedical Inc ROCO:6999
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of NT$0.0 Mil mean?
Han Biomedical (ROCO:6999) has a NonCurrent Deferred Liabilities of NT$0.0 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Han Biomedical and its competitors.
Is Han Biomedical's NonCurrent Deferred Liabilities too high?
Han Biomedical's current NonCurrent Deferred Liabilities is NT$0.0 Mil. Overall, Han Biomedical has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Han Biomedical's NonCurrent Deferred Liabilities of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Han Biomedical and its competitors. Han Biomedical's current NonCurrent Deferred Liabilities is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current NonCurrent Deferred Liabilities of NT$0.0 Mil. The current NonCurrent Deferred Liabilities is NT$0.0 Mil. Han Biomedical's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current NonCurrent Deferred Liabilities is NT$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
32GF Score

Get the complete analysis for ROCO:6999

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.45
Price